172 related articles for article (PubMed ID: 10838448)
1. Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
Ghosh K; Shetty S; Pathare A; Mohanty D
Acta Haematol; 2000; 103(2):67-72. PubMed ID: 10838448
[TBL] [Abstract][Full Text] [Related]
2. Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors.
Ghosh K; Shetty S; Jijina F; Mohanty D
Haemophilia; 2004 Jan; 10(1):58-62. PubMed ID: 14962221
[TBL] [Abstract][Full Text] [Related]
3. Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency.
Lalwani RB; Stricker RB
Am J Med Sci; 1992 Jun; 303(6):398-401. PubMed ID: 1605170
[TBL] [Abstract][Full Text] [Related]
4. Management of factor VIII inhibitors: evolution and current status.
Bloom AL
Haemostasis; 1992; 22(5):268-75. PubMed ID: 1478538
[TBL] [Abstract][Full Text] [Related]
5. Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.
Reust DL; Reeves ST; Abernathy JH; Dixon JA; Gaillard WF; Mukherjee R; Koval CN; Stroud RE; Spinale FG
Ann Thorac Surg; 2010 May; 89(5):1538-45. PubMed ID: 20417774
[TBL] [Abstract][Full Text] [Related]
6. Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.
Sahu S; Raipancholia R; Pardiwalla FK; Pathare AV
J Postgrad Med; 1996; 42(3):88-90. PubMed ID: 9715327
[TBL] [Abstract][Full Text] [Related]
7. EFFECT OF ε-AMINOCAPROIC ACID ON FIBRINOLYSIS IN PLASMA OF ASIAN ELEPHANTS (ELEPHAS MAXIMUS).
Kaye S; Abou-Madi N; Fletcher DJ
J Zoo Wildl Med; 2016 Jun; 47(2):397-404. PubMed ID: 27468009
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
[No Abstract] [Full Text] [Related]
9. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
Zwahlen H; Beck EA
Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
[TBL] [Abstract][Full Text] [Related]
11. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
13. Unexpected higher blood loss associated with higher dose ε-aminocaproic acid in pediatric scoliosis surgery.
Lam H; Austin T; Nguyen T; Martus J; Schoenecker J
J Pediatr Orthop B; 2019 Jan; 28(1):40-44. PubMed ID: 30199414
[TBL] [Abstract][Full Text] [Related]
14. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII.
Gordon EM; Mungo R; Goldsmith JC
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):107-10. PubMed ID: 8447550
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
[TBL] [Abstract][Full Text] [Related]
16. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report.
Prandota J; Pankow-Prandota L; Kotecki L; Noga L
Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Ozelo MC; Svirin P; Larina L
Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
[TBL] [Abstract][Full Text] [Related]
18. Anti-factor-VIII inhibitors in haemophilia.
Lancet; 1989 Aug; 2(8659):363-4. PubMed ID: 2569554
[No Abstract] [Full Text] [Related]
19. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.
Hay CR; Ollier W; Pepper L; Cumming A; Keeney S; Goodeve AC; Colvin BT; Hill FG; Preston FE; Peake IR
Thromb Haemost; 1997 Feb; 77(2):234-7. PubMed ID: 9157572
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic role of epsilon-aminocaproic acid (EACA) for dental extractions in hemophiliacs.
Walsh PN; Rizza CR; Evans BE; Aledort LM
Ann N Y Acad Sci; 1975 Jan; 240():267-76. PubMed ID: 1078619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
